New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|July 1, 2007
The American Journal of Managed Care
- July 2007
- Volume 13
- Issue 7
Szpunar et al (Am J Manag Care. 2007;13[pt1]:313-315)
Advertisement
In the article by Szpunar et al (Am J Manag Care. 2007;13[pt1]:313-315), the e-mail address listed for Dr Szpunar was incorrect. The correct e-mail address is: susan.szpunar@stjohn.org.
Articles in this issue
about 19 years ago
Liu et al (Am J Manag Care. 2007;13[suppl 3]:S80)about 19 years ago
Effect of Cost-sharing Changes on Self-monitoring of Blood GlucoseAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.
Simple operational changes are proving more effective at closing gaps in cardiovascular-kidney-metabolic (CKM) syndrome care than education campaigns alone, according to panelists at at Population Health Roundtable
Panelists at AJMC roundtables in Philadelphia, Boston, Washington, DC, and Chicago traced why atopic dermatitis stays undertreated despite new therapies.
Eye care access for underserved patients with diabetes is limited and poorly understood. We identified barriers and innovative solutions to improve overall care and establish evidence-based practices.
Patient understanding should be treated as a measurable equity outcome, not an assumed byproduct of care.
Advertisement
Advertisement
Trending on AJMC
1
Delayed Dupilumab Raises Asthma Costs 32%: Nicola Hanania, MD
2
Regorafenib Prescribing in Advanced GIST Deviates From Guidelines
3
Secondary T-Cell Cancers After CAR T: Rare, Real, and Worth Watching
4
FDA Expands Finerenone Approval to CKD Associated With Type 1 Diabetes
5